These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 32695876)

  • 1. Monocarboxylate Transporter 4 Is a Therapeutic Target in Non-small Cell Lung Cancer with Aerobic Glycolysis Preference.
    Kuo TC; Huang KY; Yang SC; Wu S; Chung WC; Chang YL; Hong TM; Wang SP; Chen HY; Hsiao TH; Yang PC
    Mol Ther Oncolytics; 2020 Sep; 18():189-201. PubMed ID: 32695876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monocarboxylate transporter 4 protects against myocardial ischemia/reperfusion injury by inducing oxidative phosphorylation/glycolysis interconversion and inhibiting oxidative stress.
    Pan Q; Xie X; Yuan Q
    Clin Exp Pharmacol Physiol; 2023 Dec; 50(12):954-963. PubMed ID: 37771072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocarboxylate Transporter 4 in Cancer-Associated Fibroblasts Is a Driver of Aggressiveness in Aerodigestive Tract Cancers.
    Domingo-Vidal M; Whitaker-Menezes D; Mollaee M; Lin Z; Tuluc M; Philp N; Johnson JM; Zhan T; Curry J; Martinez-Outschoorn U
    Front Oncol; 2022; 12():906494. PubMed ID: 35814364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TP53 Induced Glycolysis and Apoptosis Regulator and Monocarboxylate Transporter 4 drive metabolic reprogramming with c-MYC and NFkB activation in breast cancer.
    Roche ME; Ko YH; Domingo-Vidal M; Lin Z; Whitaker-Menezes D; Birbe RC; Tuluc M; Győrffy B; Caro J; Philp NJ; Bartrons R; Martinez-Outschoorn U
    Int J Cancer; 2023 Nov; 153(9):1671-1683. PubMed ID: 37497753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function.
    Martinez-Outschoorn U; Sotgia F; Lisanti MP
    Semin Oncol; 2014 Apr; 41(2):195-216. PubMed ID: 24787293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in metabolism between adeno- and squamous cell non-small cell lung carcinomas: spatial distribution and prognostic value of GLUT1 and MCT4.
    Meijer TW; Schuurbiers OC; Kaanders JH; Looijen-Salamon MG; de Geus-Oei LF; Verhagen AF; Lok J; van der Heijden HF; Rademakers SE; Span PN; Bussink J
    Lung Cancer; 2012 Jun; 76(3):316-23. PubMed ID: 22153830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer metabolism, stemness and tumor recurrence: MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer.
    Curry JM; Tuluc M; Whitaker-Menezes D; Ames JA; Anantharaman A; Butera A; Leiby B; Cognetti DM; Sotgia F; Lisanti MP; Martinez-Outschoorn UE
    Cell Cycle; 2013 May; 12(9):1371-84. PubMed ID: 23574725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The monocarboxylate transporter 4 is required for glycolytic reprogramming and inflammatory response in macrophages.
    Tan Z; Xie N; Banerjee S; Cui H; Fu M; Thannickal VJ; Liu G
    J Biol Chem; 2015 Jan; 290(1):46-55. PubMed ID: 25406319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocarboxylate transporter 4 involves in energy metabolism and drug sensitivity in hypoxia.
    Yamaguchi A; Mukai Y; Sakuma T; Narumi K; Furugen A; Yamada Y; Kobayashi M
    Sci Rep; 2023 Jan; 13(1):1501. PubMed ID: 36707650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Monocarboxylate Transporter 4 (
    Markou A; Tzanikou E; Kallergi G; Pantazaka E; Georgoulias V; Kotsakis A; Lianidou E
    Front Cell Dev Biol; 2021; 9():641978. PubMed ID: 33968927
    [No Abstract]   [Full Text] [Related]  

  • 11. Genome-wide RNA interference analysis of renal carcinoma survival regulators identifies MCT4 as a Warburg effect metabolic target.
    Gerlinger M; Santos CR; Spencer-Dene B; Martinez P; Endesfelder D; Burrell RA; Vetter M; Jiang M; Saunders RE; Kelly G; Dykema K; Rioux-Leclercq N; Stamp G; Patard JJ; Larkin J; Howell M; Swanton C
    J Pathol; 2012 Jun; 227(2):146-56. PubMed ID: 22362593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial and glycolytic metabolic compartmentalization in diffuse large B-cell lymphoma.
    Gooptu M; Whitaker-Menezes D; Sprandio J; Domingo-Vidal M; Lin Z; Uppal G; Gong J; Fratamico R; Leiby B; Dulau-Florea A; Caro J; Martinez-Outschoorn U
    Semin Oncol; 2017 Jun; 44(3):204-217. PubMed ID: 29248132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydroartemisinin and artesunate inhibit aerobic glycolysis via suppressing c-Myc signaling in non-small cell lung cancer.
    Zhang Y; Wang Y; Li Y; Huang C; Xiao X; Zhong Z; Tang J; Lu H; Tang Y; Yang J
    Biochem Pharmacol; 2022 Apr; 198():114941. PubMed ID: 35149053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactate-induced MRP1 expression contributes to metabolism-based etoposide resistance in non-small cell lung cancer cells.
    Dong Q; Zhou C; Ren H; Zhang Z; Cheng F; Xiong Z; Chen C; Yang J; Gao J; Zhang Y; Xu L; Fang J; Cao Y; Wei H; Wu Z
    Cell Commun Signal; 2020 Oct; 18(1):167. PubMed ID: 33097055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-16-5p regulates aerobic glycolysis and tumorigenesis of NSCLC cells via LDH-A/lactate/NF-κB signaling.
    Arora S; Singh P; Tabassum G; Dohare R; Syed MA
    Life Sci; 2022 Sep; 304():120722. PubMed ID: 35714705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting MCT4 to reduce lactic acid secretion and glycolysis for treatment of neuroendocrine prostate cancer.
    Choi SYC; Ettinger SL; Lin D; Xue H; Ci X; Nabavi N; Bell RH; Mo F; Gout PW; Fleshner NE; Gleave ME; Collins CC; Wang Y
    Cancer Med; 2018 Jul; 7(7):3385-3392. PubMed ID: 29905005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SYVN1-mediated ubiquitylation directs localization of MCT4 in the plasma membrane to promote the progression of lung adenocarcinoma.
    Zhao M; Huang C; Yang L; Pan B; Yang S; Chang J; Jin Y; Zhao G; Yue D; Qie S; Ren L
    Cell Death Dis; 2023 Oct; 14(10):666. PubMed ID: 37816756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Targeting of Tumor Cells and Tumor Immune Microenvironment Vulnerabilities.
    Kalyanaraman B; Cheng G; Hardy M
    Front Oncol; 2022; 12():816504. PubMed ID: 35756631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formosanin C inhibits non-small-cell lung cancer progression by blocking MCT4/CD147-mediated lactate export.
    Li J; Wu Z; Chen G; Wang X; Zhu X; Zhang Y; Zhang R; Wu W; Zhu Y; Ma L; Yu H
    Phytomedicine; 2023 Jan; 109():154618. PubMed ID: 36610137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional heterogeneity of MCT1 and MCT4 in metabolic reprogramming affects osteosarcoma growth and metastasis.
    Sheng G; Gao Y; Wu H; Liu Y; Yang Y
    J Orthop Surg Res; 2023 Feb; 18(1):131. PubMed ID: 36814318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.